Glox Therapeutics Limited

SC760230

active

Private Limited Company

scotland

Companies House

Health Score

65 / 100

Some Concerns

25/30

Filing

0/30

Financial

40/40

Risk

No risk factors detected.

Details

JOHN ARBUTHNOTT BUILDING STRATHCLYDE UNIVERSITY OF PHARMACY & BIOMEDICAL, GLASGOW, G4 0RE

Incorporated 27/02/2023

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 26/02/2026

Due 12/03/2027

On track

Industry

72110

Research and experimental development on biotechnology

72190

Other research and experimental development on natural sciences and engineering

Officers

Professor Daniel Walker

director · Since 24/10/2023

NONE

BRITISH · UNITED KINGDOM · Age 53

Dr Michael Stephen Murray

director · Since 06/02/2025

DIRECTOR

SCOTTISH · ENGLAND · Age 62

Also on 4 other boards

Dr Paul Nicklin

director · Since 12/08/2025

INVESTMENT MANAGER

BRITISH · GERMANY · Age 59

Persons with Significant Control

Former PSCs

G U Holdings Limited

Ceased 12/04/2023

Professor Daniel Walker

Ceased 24/10/2023

Professor Colin Kleanthous

Ceased 13/04/2023